Severe Adult Atopic Dermatitis: Clinical Challenges
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Dermatology,Immunology and Allergy
Reference3 articles.
1. Management recommendations for dupilumab partial and non-durable responders in atopic dermatitis;Am J Clin Dermatol,2019
2. The burden of atopic dermatitis: summary of a report for the National Eczema Association;J Invest Dermatol,2017
3. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis;J Allergy Clin Immunol,2019
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Evaluating the Clinical Meaning of Dermatology Life Quality Index Scores Between Different Phenotypes of Atopic Dermatitis in Patients Before and After Biologic Therapy With Dupilumab;Dermatitis®;2024-04-26
2. Real‐world efficacy of 2% crisaborole ointment on chronic hyperplasia lesions in 49 patients with atopic dermatitis;International Journal of Dermatology;2024-03-28
3. Dupilumab and Atopic Dermatitis Flares: An Observational Study to Identify Common Clinical Features in Patients Who Have Exacerbations Despite Biological Therapy;Dermatitis®;2024-02-01
4. An Observational Study of Early Treatment Response and Predictors of Dupilumab in the Treatment of Moderate‐to‐Severe Atopic Dermatitis;Dermatologic Therapy;2024-01
5. Combination treatment with monoclonal antibodies: Dupilumab and ustekinumab for the treatment of severe atopic dermatitis and Crohn disease;Australasian Journal of Dermatology;2023-11-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3